Chong H. Kim is a HEOR consultant at Stratevi LLC. His research interests include real-world evidence/observational research, cost-effectiveness analysis, predictive modeling, and spatial statistics. He is a Manager at Stratevi, where he conducts research specifically to determine the value of pharmaceutical interventions.


  • Observational research
  • Cost-effectiveness analysis
  • Predictive modeling
  • Spatial statistics


  • PhD in Pharmaceutical Outcomes Research, 2020

    University of Colorado, Anschutz Medical Campus

  • MPH in Health Policy & Management, 2014

    Columnbia University

  • BSc in Biochemsitry & Molecular Biology, 2009

    Michigan State University






DB analysis






Jul 2020 – Present California

Responsibilities include:

  • Executing HEOR projects from proposal development to evidence dissemination

Associate Manager


Aug 2019 – Jul 2020 California

Responsibilities include:

  • Supporting projects through analysis/modeling

PhD Researcher

Colorado University

Aug 2015 – Jul 2019 Colorado
Conducted research to understand the impact of asthma medication use on health outcomes.

Recent Posts

Generating publication ready tables with {gtsummary} and {flextable}

Publication-ready tables with {gtsummary} and {flextable} So, I’ve been using R for a while now and I haven’t really found a good …

tidymodels vs mlr3

Comparison of packages for prediction: {tidymodels} vs. {mlr3} So I wrote a lot of prediction code for my dissertation using {caret} …

Sample Size Calculation with R Extended

Sample Size Caluclation in R… Extended! This is an extension from a post I saw here. When thinking about study designs for a trial that …

Tidy evaluation

Tidy evaluation… extended! This is an extension from a post I saw here. There are several instances when I want to be able to use …

Timeline Graph

Timeline graphs… extended! So, I was checking a few online forums and I found someone asking about replicating a timeline graph and I …

Recent & Upcoming Talks

Recent Publications

Quickly discover relevant content by filtering publications.

Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United States

Abstract Aims To examine the impact of active only (A) vs. combined passive & active (PA) hemostatic products on bleeding-related …

An economic analysis of different treatments for bleeding in patients with acquired haemophilia

Background Acquired haemophilia A (AHA), with potentially high risk of morbidity and mortality, occurs as a result of inhibitors …